Prime Medicine, Inc. (PRME)
3.255
-0.14
(-3.98%)
USD |
NASDAQ |
Aug 24, 16:00
3.26
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Total Assets (Quarterly) : 249.04M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 249.04M |
| March 31, 2026 | 294.73M |
| December 31, 2025 | 616.64M |
| September 30, 2025 | 385.01M |
| June 30, 2025 | 279.01M |
| March 31, 2025 | 328.16M |
| December 31, 2024 | 490.14M |
| September 30, 2024 | 332.78M |
| June 30, 2024 | 259.70M |
| March 31, 2024 | 311.38M |
| December 31, 2023 | 316.90M |
| September 30, 2023 | 239.14M |
| Date | Value |
|---|---|
| June 30, 2023 | 280.86M |
| March 31, 2023 | 316.95M |
| December 31, 2022 | 430.91M |
| September 30, 2022 | 215.26M |
| June 30, 2022 | 247.60M |
| March 31, 2022 | 244.55M |
| December 31, 2021 | 301.86M |
| September 30, 2021 | 315.19M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 54.78M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 1.386B |
| Twist Bioscience Corp. | 672.44M |
| Sana Biotechnology, Inc. | 431.52M |
| Generate Biomedicines, Inc. | 561.69M |
| Intellia Therapeutics, Inc. | 857.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 209.23M |
| Shareholders Equity (Quarterly) | 39.81M |
| Debt to Equity Ratio | 2.825 |
| Current Ratio | 3.054 |
| Net Debt Paydown Yield | 0.26% |